Literature DB >> 26068870

Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient.

Kayoko Hayakawa1, Tomohiko Takasaki2, Hiroko Tsunemine3, Shuzo Kanagawa4, Satoshi Kutsuna4, Nozomi Takeshita4, Momoko Mawatari4, Yoshihiro Fujiya4, Kei Yamamoto4, Norio Ohmagari4, Yasuyuki Kato4.   

Abstract

The duration of a protective level of yellow fever antibodies after autologous hematopoietic stem cell transplantation in a previously vaccinated person is unclear. The case of a patient who had previously been vaccinated for yellow fever and who remained seropositive for 22 months after autologous peripheral blood stem cell transplantation for malignant lymphoma is described herein.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autologous hematopoietic stem cell transplantation; Bone marrow transplantation; Seropositivity; Vaccination; Yellow fever

Mesh：

Substances：

Year:  2015        PMID： 26068870     DOI： 10.1016/j.ijid.2015.05.025

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


  2 in total

1.  Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate.

Authors:  Christina Ekenberg; Nina Friis-Møller; Thomas Ulstrup; Claus Aalykke
Journal:  BMJ Case Rep       Date:  2016-08-29

2. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.